{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:50:33Z","timestamp":1782755433827,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enterovirus 71 (EV71), one of the major pathogens of Hand, foot and mouth disease (HFMD), results in millions of infections and hundreds of deaths each year in Southeast Asia. Biased infection and variable clinical manifestations of EV71 HFMD indicated that host genetic background played an important role in the occurrence and development of the disease. We identified the mRNA profiles of EV71 HFMD patients, which type I interferon (IFN) pathway related genes were down-regulated. Four single nucleotide polymorphisms (SNPs) of type I IFN receptor 1 (IFNAR1) were chosen to analyze their relationships to EV71 infection. We found that genotype GG of promoter variant rs2843710 was associated with the susceptibility and severity to EV71 HFMD. In addition, we assessed the regulatory effects of rs2843710 to IFN stimulated genes (ISGs) and found that the expressions of IFNAR1, OAS1 and MX1 were significantly lower in patients with rs2843710 genotype GG. And rs2843710 allele G showed weaker transcriptional activity compared with allele C. Our study indicated that rs2843710 of IFNAR1 was associated with the susceptibility and severity of EV71 HFMD in Chinese Han populations, acting as a functional polymorphism by regulating ISGs expression, such as OAS1 and MX1.<\/jats:p>","DOI":"10.1038\/srep18541","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T10:31:54Z","timestamp":1450434714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection"],"prefix":"10.1038","volume":"5","author":[{"given":"Rongrong","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Fu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"BFsrep18541_CR1","doi-asserted-by":"publisher","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","volume":"7","author":"FC Zhu","year":"2012","unstructured":"Zhu, F. C. et al. Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7, e37206 (2012).","journal-title":"PLoS One"},{"key":"BFsrep18541_CR2","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/1743-422X-8-508","volume":"8","author":"F Yang","year":"2011","unstructured":"Yang, F. et al. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol J 8, 508 (2011).","journal-title":"Virol J"},{"key":"BFsrep18541_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcv.2012.04.021","volume":"54","author":"H Ni","year":"2012","unstructured":"Ni, H. et al. Epidemiological and etiological characteristics of hand, foot and mouth disease in Ningbo, China, 2008-2011. J Clin Virol 54, 342\u20138 (2012).","journal-title":"J Clin Virol"},{"key":"BFsrep18541_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1086\/314032","volume":"31","author":"LG Chan","year":"2000","unstructured":"Chan, L. G. et al. Deaths of children during an outbreak of hand, foot and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis 31, 678\u201383 (2000).","journal-title":"Clin Infect Dis"},{"key":"BFsrep18541_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/376998","volume":"188","author":"SM Wang","year":"2003","unstructured":"Wang, S. M. et al. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis 188, 564\u201370 (2003).","journal-title":"J Infect Dis"},{"key":"BFsrep18541_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/520149","volume":"29","author":"SM Wang","year":"1999","unstructured":"Wang, S. M. et al. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29, 184\u201390 (1999).","journal-title":"Clin Infect Dis"},{"key":"BFsrep18541_CR7","doi-asserted-by":"publisher","first-page":"e25662","DOI":"10.1371\/journal.pone.0025662","volume":"6","author":"X Tan","year":"2011","unstructured":"Tan, X. et al. The persistent circulation of enterovirus 71 in People\u2019s Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6, e25662 (2011).","journal-title":"PLoS One"},{"key":"BFsrep18541_CR8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1474-4422(08)70207-2","volume":"7","author":"J Qiu","year":"2008","unstructured":"Qiu, J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol 7, 868\u20139 (2008).","journal-title":"Lancet Neurol"},{"key":"BFsrep18541_CR9","unstructured":"National Health and Family Planning Commission of the People\u2019s Republic of China. Ministry of Health released the National Notifiable Infectious Diseases Overview of January 2012 and 2011. Epidemic information. (2012) Available at: http:\/\/www.moh.gov.cn\/wsb\/pyqxx\/201202\/54106.shtml. (Accessed: 10th February 2012)."},{"key":"BFsrep18541_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(05)74253-7","volume":"356","author":"K Ahmad","year":"2000","unstructured":"Ahmad, K. Hand, foot and mouth disease outbreak reported in Singapore. Lancet 356, 1338 (2000).","journal-title":"Lancet"},{"key":"BFsrep18541_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJM199909233411301","volume":"341","author":"M Ho","year":"1999","unstructured":"Ho, M. et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med 341, 929\u201335 (1999).","journal-title":"N Engl J Med"},{"key":"BFsrep18541_CR12","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1128\/JCM.00563-09","volume":"47","author":"F Yang","year":"2009","unstructured":"Yang, F. et al. Enterovirus 71 outbreak in the People\u2019s Republic of China in 2008. J Clin Microbiol 47, 2351\u20132 (2009).","journal-title":"J Clin Microbiol"},{"key":"BFsrep18541_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1743-422X-7-94","volume":"7","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J 7, 94 (2010).","journal-title":"Virol J"},{"key":"BFsrep18541_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1743-422X-9-8","volume":"9","author":"W Xu","year":"2012","unstructured":"Xu, W. et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J 9, 8 (2012).","journal-title":"Virol J"},{"key":"BFsrep18541_CR15","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMoa065954","volume":"356","author":"LY Chang","year":"2007","unstructured":"Chang, L. Y. et al. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356, 1226\u201334 (2007).","journal-title":"N Engl J Med"},{"key":"BFsrep18541_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJM199909233411302","volume":"341","author":"CC Huang","year":"1999","unstructured":"Huang, C. C. et al. Neurologic complications in children with enterovirus 71 infection. N Engl J Med 341, 936\u201342 (1999).","journal-title":"N Engl J Med"},{"key":"BFsrep18541_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.micinf.2010.03.006","volume":"12","author":"KF Weng","year":"2010","unstructured":"Weng, K. F., Chen, L. L., Huang, P. N. & Shih, S. R. Neural pathogenesis of enterovirus 71 infection. Microbes Infect 12, 505\u201310 (2010).","journal-title":"Microbes Infect"},{"key":"BFsrep18541_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00439-013-1367-3","volume":"133","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet 133, 187\u201397 (2014).","journal-title":"Hum Genet"},{"key":"BFsrep18541_CR19","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/iji.12134","volume":"41","author":"Y Cai","year":"2014","unstructured":"Cai, Y. et al. Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease. Int J Immunogenet 41, 384\u201392 (2014).","journal-title":"Int J Immunogenet"},{"key":"BFsrep18541_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3892\/br.2013.64","volume":"1","author":"J Yang","year":"2013","unstructured":"Yang, J., Chen, Z. Z., Lv, T. G., Liu, P. P. & Chen, Z. B. Association of IP-10 gene polymorphism with susceptibility to Enterovirus 71 infection. Biomed Rep 1, 410\u2013412 (2013).","journal-title":"Biomed Rep"},{"key":"BFsrep18541_CR21","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3109\/00365548.2011.649490","volume":"44","author":"J Yang","year":"2012","unstructured":"Yang, J. et al. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis 44, 465\u20139 (2012).","journal-title":"Scand J Infect Dis"},{"key":"BFsrep18541_CR22","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.clinbiochem.2013.10.009","volume":"46","author":"JA Li","year":"2013","unstructured":"Li, J. A., Chen, Z. B., Lv, T. G., Han, Z. L. & Liu, P. P. Impact of endothelial nitric oxide synthase gene polymorphism on severity of enterovirus 71-infection in Chinese children. Clin Biochem 46, 1842\u20137 (2013).","journal-title":"Clin Biochem"},{"key":"BFsrep18541_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00011-014-0724-6","volume":"63","author":"JA Li","year":"2014","unstructured":"Li, J. A., Chen, Z. B., Lv, T. G. & Han, Z. L. Genetic polymorphism of CCL2-2518, CXCL10-201, IL8+781 and susceptibility to severity of Enterovirus-71 infection in a Chinese population. Inflamm Res 63, 549\u201356 (2014).","journal-title":"Inflamm Res"},{"key":"BFsrep18541_CR24","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.4049\/jimmunol.175.5.2851","volume":"175","author":"M Yoneyama","year":"2005","unstructured":"Yoneyama, M. et al. Shared and unique functions of the DExD\/H-box helicases RIG-I, MDA5 and LGP2 in antiviral innate immunity. J Immunol 175, 2851\u20138 (2005).","journal-title":"J Immunol"},{"key":"BFsrep18541_CR25","doi-asserted-by":"crossref","first-page":"18747","DOI":"10.1016\/S0021-9258(17)32231-7","volume":"269","author":"CM Cleary","year":"1994","unstructured":"Cleary, C. M., Donnelly, R. J., Soh, J., Mariano, T. M. & Pestka, S. Knockout and reconstitution of a functional human type I interferon receptor complex. J Biol Chem 269, 18747\u20139 (1994).","journal-title":"J Biol Chem"},{"key":"BFsrep18541_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0092-8674(94)90154-6","volume":"77","author":"D Novick","year":"1994","unstructured":"Novick, D., Cohen, B. & Rubinstein, M. The human interferon alpha\/beta receptor: characterization and molecular cloning. Cell 77, 391\u2013400 (1994).","journal-title":"Cell"},{"key":"BFsrep18541_CR27","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/MMBR.00027-06","volume":"70","author":"MA Garcia","year":"2006","unstructured":"Garcia, M. A. et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70, 1032\u201360 (2006).","journal-title":"Microbiol Mol Biol Rev"},{"key":"BFsrep18541_CR28","doi-asserted-by":"publisher","first-page":"6112","DOI":"10.1038\/sj.onc.1203127","volume":"18","author":"BR Williams","year":"1999","unstructured":"Williams, B. R. PKR; a sentinel kinase for cellular stress. Oncogene 18, 6112\u201320 (1999).","journal-title":"Oncogene"},{"key":"BFsrep18541_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/jir.1994.14.101","volume":"14","author":"RH Silverman","year":"1994","unstructured":"Silverman, R. H. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res 14, 101\u20134 (1994).","journal-title":"J Interferon Res"},{"key":"BFsrep18541_CR30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1034\/j.1600-0854.2002.31003.x","volume":"3","author":"O Haller","year":"2002","unstructured":"Haller, O. & Kochs, G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3, 710\u20137 (2002).","journal-title":"Traffic"},{"key":"BFsrep18541_CR31","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","volume":"81","author":"S Goodbourn","year":"2000","unstructured":"Goodbourn, S., Didcock, L. & Randall, R. E. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81, 2341\u201364 (2000).","journal-title":"J Gen Virol"},{"key":"BFsrep18541_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1089\/jir.2009.0065","volume":"29","author":"CX George","year":"2009","unstructured":"George, C. X. et al. Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products. J Interferon Cytokine Res 29, 477\u201387 (2009).","journal-title":"J Interferon Cytokine Res"},{"key":"BFsrep18541_CR33","doi-asserted-by":"publisher","first-page":"29350","DOI":"10.1074\/jbc.M109.045146","volume":"284","author":"AM Toth","year":"2009","unstructured":"Toth, A. M., Li, Z., Cattaneo, R. & Samuel, C. E. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem 284, 29350\u20136 (2009).","journal-title":"J Biol Chem"},{"key":"BFsrep18541_CR34","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1128\/JVI.06687-11","volume":"86","author":"J Lu","year":"2012","unstructured":"Lu, J. et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol 86, 3767\u201376 (2012).","journal-title":"J Virol"},{"key":"BFsrep18541_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/vim.2013.0127","volume":"27","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Viral Immunol 27, 267\u201376 (2014).","journal-title":"Viral Immunol"},{"key":"BFsrep18541_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2893.2008.01040.x","volume":"16","author":"J Zhou","year":"2009","unstructured":"Zhou, J. et al. A non-synonymous single nucleotide polymorphism in IFNAR1 affects susceptibility to chronic hepatitis B virus infection. J Viral Hepat 16, 45\u201352 (2009).","journal-title":"J Viral Hepat"},{"key":"BFsrep18541_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/vim.2009.0102","volume":"23","author":"XX He","year":"2010","unstructured":"He, X. X. et al. Persistent effect of IFNAR-1 genetic polymorphism on the long-term pathogenesis of chronic HBV infection. Viral Immunol 23, 251\u20137 (2010).","journal-title":"Viral Immunol"},{"key":"BFsrep18541_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.biopha.2006.08.002","volume":"60","author":"G Diop","year":"2006","unstructured":"Diop, G. et al. Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed Pharmacother 60, 569\u201377 (2006).","journal-title":"Biomed Pharmacother"},{"key":"BFsrep18541_CR39","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1128\/JVI.78.15.8219-8228.2004","volume":"78","author":"V van Pesch","year":"2004","unstructured":"van Pesch, V., Lanaya, H., Renauld, J. C. & Michiels, T. Characterization of the murine alpha interferon gene family. J Virol 78, 8219\u201328 (2004).","journal-title":"J Virol"},{"key":"BFsrep18541_CR40","first-page":"239","volume":"61","author":"RM Roberts","year":"2003","unstructured":"Roberts, R. M., Ezashi, T., Rosenfeld, C. S., Ealy, A. D. & Kubisch, H. M. Evolution of the interferon tau genes and their promoters and maternal-trophoblast interactions in control of their expression. Reprod Suppl 61, 239\u201351 (2003).","journal-title":"Reprod Suppl"},{"key":"BFsrep18541_CR41","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy, D. E. & Darnell, J. E., Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3, 651\u201362 (2002).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFsrep18541_CR42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","volume":"69","author":"MJ de Veer","year":"2001","unstructured":"de Veer, M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69, 912\u201320 (2001).","journal-title":"J Leukoc Biol"},{"key":"BFsrep18541_CR43","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","volume":"95","author":"SD Der","year":"1998","unstructured":"Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95, 15623\u20138 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep18541_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/infdis\/153.3.498","volume":"153","author":"O Sasaki","year":"1986","unstructured":"Sasaki, O., Karaki, T. & Imanishi, J. Protective effect of interferon on infections with hand, foot and mouth disease virus in newborn mice. J Infect Dis 153, 498\u2013502 (1986).","journal-title":"J Infect Dis"},{"key":"BFsrep18541_CR45","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","volume":"86","author":"ML Liu","year":"2005","unstructured":"Liu, M. L. et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86, 3263\u20139 (2005).","journal-title":"J Gen Virol"},{"key":"BFsrep18541_CR46","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1017\/S0007114513004133","volume":"111","author":"S Chen","year":"2014","unstructured":"Chen, S., Yang, Y., Xu, J., Su, L. & Wang, W. Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro. Br J Nutr 111, 1586\u201393 (2014).","journal-title":"Br J Nutr"},{"key":"BFsrep18541_CR47","doi-asserted-by":"publisher","first-page":"e1003231","DOI":"10.1371\/journal.ppat.1003231","volume":"9","author":"B Wang","year":"2013","unstructured":"Wang, B. et al. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9, e1003231 (2013).","journal-title":"PLoS Pathog"},{"key":"BFsrep18541_CR48","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1128\/JVI.02491-09","volume":"84","author":"X Lei","year":"2010","unstructured":"Lei, X. et al. The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses. J Virol 84, 8051\u201361 (2010).","journal-title":"J Virol"},{"key":"BFsrep18541_CR49","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/jmv.23377","volume":"84","author":"YP Lee","year":"2012","unstructured":"Lee, Y. P., Wang, Y. F., Wang, J. R., Huang, S. W. & Yu, C. K. Enterovirus 71 blocks selectively type I interferon production through the 3C viral protein in mice. J Med Virol 84, 1779\u201389 (2012).","journal-title":"J Med Virol"},{"key":"BFsrep18541_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jhep.2006.08.017","volume":"46","author":"J Zhou","year":"2007","unstructured":"Zhou, J. et al. Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection. J Hepatol 46, 198\u2013205 (2007).","journal-title":"J Hepatol"},{"key":"BFsrep18541_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.meegid.2014.10.030","volume":"29","author":"K Kanchan","year":"2015","unstructured":"Kanchan, K. et al. Interferon-gamma (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-alpha receptor (IFNAR1) associated with enhanced malaria susceptibility in Indian populations. Infect Genet Evol 29, 6\u201314 (2015).","journal-title":"Infect Genet Evol"},{"key":"BFsrep18541_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MOT.0b013e328351093b","volume":"17","author":"MA Rifai","year":"2012","unstructured":"Rifai, M. A. & Sabouni, M. A. Utilizing genomic polymorphisms to personalize hepatitis C therapies. Curr Opin Organ Transplant 17, 198\u2013203 (2012).","journal-title":"Curr Opin Organ Transplant"},{"key":"BFsrep18541_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2009.03.020","volume":"51","author":"J Zhou","year":"2009","unstructured":"Zhou, J. et al. Functional dissection of an IFN-alpha\/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection. J Hepatol 51, 322\u201332 (2009).","journal-title":"J Hepatol"},{"key":"BFsrep18541_CR54","doi-asserted-by":"publisher","first-page":"e92745","DOI":"10.1371\/journal.pone.0092745","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang, J. et al. Epidemiological analysis, detection and comparison of space-time patterns of Beijing hand-foot-mouth disease (2008\u20132012). PLoS One 9, e92745 (2014).","journal-title":"PLoS One"},{"key":"BFsrep18541_CR55","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clim.2006.11.009","volume":"123","author":"X Chen","year":"2007","unstructured":"Chen, X. et al. CD4 (+) CD25 (+) FoxP3 (+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123, 50\u20139 (2007).","journal-title":"Clin Immunol"},{"key":"BFsrep18541_CR56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1600-0404.2007.00968.x","volume":"118","author":"AM Vallittu","year":"2008","unstructured":"Vallittu, A. M., Eralinna, J. P., Ilonen, J., Salmi, A. A. & Waris, M. MxA protein assay for optimal monitoring of IFN-beta bioactivity in the treatment of MS patients. Acta Neurol Scand 118, 12\u20137 (2008).","journal-title":"Acta Neurol Scand"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep18541","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep18541.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T01:01:19Z","timestamp":1672966879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep18541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,22]]}},"alternative-id":["BFsrep18541"],"URL":"https:\/\/doi.org\/10.1038\/srep18541","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,18]]},"assertion":[{"value":"28 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18541"}}